Every­one wants an ADC: GSK pays $85M up­front for ex-Chi­na rights to Han­soh Phar­ma's an­ti­body-drug con­ju­gate

MADRID — GSK has agreed to li­cense an an­ti­body-drug con­ju­gate from Han­soh Phar­ma for $85 mil­lion up­front, in ex­change for glob­al rights out­side of Chi­na, Hong …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER